Correlation Between Enorama Pharma and Maven Wireless

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enorama Pharma and Maven Wireless at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enorama Pharma and Maven Wireless into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enorama Pharma AB and Maven Wireless Sweden, you can compare the effects of market volatilities on Enorama Pharma and Maven Wireless and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enorama Pharma with a short position of Maven Wireless. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enorama Pharma and Maven Wireless.

Diversification Opportunities for Enorama Pharma and Maven Wireless

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Enorama and Maven is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Enorama Pharma AB and Maven Wireless Sweden in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maven Wireless Sweden and Enorama Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enorama Pharma AB are associated (or correlated) with Maven Wireless. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maven Wireless Sweden has no effect on the direction of Enorama Pharma i.e., Enorama Pharma and Maven Wireless go up and down completely randomly.

Pair Corralation between Enorama Pharma and Maven Wireless

Assuming the 90 days trading horizon Enorama Pharma AB is expected to generate 1.78 times more return on investment than Maven Wireless. However, Enorama Pharma is 1.78 times more volatile than Maven Wireless Sweden. It trades about -0.06 of its potential returns per unit of risk. Maven Wireless Sweden is currently generating about -0.1 per unit of risk. If you would invest  500.00  in Enorama Pharma AB on August 29, 2024 and sell it today you would lose (124.00) from holding Enorama Pharma AB or give up 24.8% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Enorama Pharma AB  vs.  Maven Wireless Sweden

 Performance 
       Timeline  
Enorama Pharma AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enorama Pharma AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Maven Wireless Sweden 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Maven Wireless Sweden has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Enorama Pharma and Maven Wireless Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enorama Pharma and Maven Wireless

The main advantage of trading using opposite Enorama Pharma and Maven Wireless positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enorama Pharma position performs unexpectedly, Maven Wireless can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maven Wireless will offset losses from the drop in Maven Wireless' long position.
The idea behind Enorama Pharma AB and Maven Wireless Sweden pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Insider Screener
Find insiders across different sectors to evaluate their impact on performance